First Author | Kang SS | Year | 2018 |
Journal | Sci Rep | Volume | 8 |
Issue | 1 | Pages | 1496 |
PubMed ID | 29367683 | Mgi Jnum | J:260154 |
Mgi Id | MGI:6148514 | Doi | 10.1038/s41598-018-19653-y |
Citation | Kang SS, et al. (2018) Staphylococcal LTA antagonizes the B cell-mitogenic potential of LPS. Sci Rep 8(1):1496 |
abstractText | Lipoteichoic acid (LTA) of Gram-positive bacteria is regarded as the counterpart biomolecule of lipopolysaccharide (LPS) of Gram-negative bacteria because of their structural and immunological similarities. Although LPS induces a strong polyclonal expansion of B cells, little is known about the effect of LTA on B cell proliferation. In the present study, we prepared LTAs from Gram-positive bacteria and examined their effect on splenic B cell proliferation. Unlike LPS, LTA did not induce B cell proliferation. Instead, Staphylococcus aureus LTA (Sa.LTA) appeared to inhibit LPS-induced B cell proliferation in vitro, ex vivo, and in vivo models. Such effect was observed neither in splenocytes from Toll-like receptor 2 (TLR2)-deficient mice nor in the purified splenic B cells. Furthermore, decreased ERK phosphorylation appeared to be responsible for this phenomenon. Collectively, our results support that Sa.LTA inhibited LPS-induced B cell proliferation through the decrease of ERK phosphorylation via TLR2 signaling pathway. |